People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Redwood Scientific Technologies, Inc. | — | Biotechnology | Seed | $5.6M | $10.5M | 2023 |
Jason Cardiff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Cardiff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Duncan | 1 | 6 |
| Brian Kennedy | 1 | 6 |
| John Harrington | 1 | 3 |
| Kevin E. Harrington | 1 | 2 |
| Jacques Poujade | 1 | 2 |
| Cardiff Jason | 1 | 1 |
| Christine Hayes | 1 | 1 |
| Jaci Warren | 1 | 1 |
| Patrick E. Moynihan | 1 | 1 |
| Jaci E. Warren | 1 | 1 |
| Jacques E. Poujade | 1 | 1 |
| Eunjung E. Cardiff | 1 | 1 |
| Christine E. Hayes | 1 | 1 |
| Jason E. Cardiff | 1 | 1 |
| Eunjung Cardiff | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.